148 related articles for article (PubMed ID: 28592127)
1. Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma.
Liu XY; Fan YC; Gao S; Zhao J; Chen LY; Li F; Wang K
Neoplasma; 2017; 64(5):745-753. PubMed ID: 28592127
[TBL] [Abstract][Full Text] [Related]
2. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
[TBL] [Abstract][Full Text] [Related]
5. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
6. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
7. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
[TBL] [Abstract][Full Text] [Related]
8. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
[TBL] [Abstract][Full Text] [Related]
9. Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma.
Li F; Fan YC; Gao S; Sun FK; Yang Y; Wang K
Genes Chromosomes Cancer; 2014 Jan; 53(1):90-7. PubMed ID: 24142767
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma.
Miao LL; Wang JW; Liu HH; Gao S; Fan YC; Wang K
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):35-42. PubMed ID: 36878837
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
[TBL] [Abstract][Full Text] [Related]
13. Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma.
Xie GF; Xu YX; Xu F; Sun LY; Ye ZL; Ma JJ; Wang HY; Shao JY
Neoplasma; 2021 Jan; 68(1):62-70. PubMed ID: 33118832
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Qian Y; Wang JW; Fang Y; Yuan XD; Fan YC; Gao S; Wang K
Med Sci Monit; 2020 Dec; 26():e927444. PubMed ID: 33320844
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
[TBL] [Abstract][Full Text] [Related]
17. Combined detection of insulin-like growth factor-binding protein 7 promoter methylation improves the diagnostic efficacy of AFP in hepatitis B virus-associated hepatocellular carcinoma.
Tao LP; Fan XP; Fan YC; Zhao J; Gao S; Wang K
Pathol Res Pract; 2018 Jan; 214(1):144-150. PubMed ID: 29108923
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
Qin Y; Yu J; Zhang M; Qin F; Lan X
Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
[TBL] [Abstract][Full Text] [Related]
20. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]